|
End-of-day quote
Korea S.E.
2026-08-13
|
5-day change | 1st Jan Change | ||
| 4,900.00 KRW | -0.51% |
|
+5.95% | -10.42% |
| 05-12 | BioNote's Net Income Jumps 925% in Q1; Shares Rise 3% | MT |
| 05-12 | Bionote Inc Q1 provisional operating profit 6.3 billion won up 35.2% Y/Y | RE |
| Market Cap | 496B 350M 303M 284M 259M 488M 33.38B 495M 3.35B 1.31B 16.71B 1.31B 1.28B 55.73B | P/E 2024 |
8.69x | P/E 2025 | -6.32x |
|---|---|---|---|---|---|
| Enterprise Value | 160B 113M 97.62M 91.51M 83.44M 157M 10.75B 160M 1.08B 421M 5.38B 423M 414M 17.95B | EV / Sales 2024 |
0.77x | EV / Sales 2025 | 1.84x |
| Free-Float |
12.56% | Yield 2024 |
4.25% | Yield 2025 | - |
| 1 day | -0.51% | ||
| 1 week | +5.95% | ||
| Current month | +7.57% | ||
| 1 month | +3.92% | ||
| 3 months | +0.41% | ||
| 6 months | -15.52% | ||
| Current year | -10.42% |
| 1 week | 4,725 |  | 5,080 |
| 1 month | 4,050 | | 5,080 |
| Current year | 4,050 | | 6,260 |
| 1 year | 4,050 | | 6,320 |
| 3 years | 3,800 | | 6,400 |
| 5 years | 3,800 | | 11,700 |
| 10 years | 3,800 | | 11,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Byung-Ki Cho
CEO | Chief Executive Officer | 58 | 2020-07-31 |
Guk-Myung Lee
DFI | Director of Finance/CFO | 54 | 2021-03-31 |
Hye-Im Cho
SAM | Sales & Marketing | 39 | 2025-03-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Young-Sik Cho
CHM | Chairman | 65 | 2023-02-28 |
Byung-Ki Cho
BRD | Director/Board Member | 58 | 2020-07-31 |
Jung-Ho Kim
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/5/25 | Free | 10,000,000 | 9.8058% | |||
| 2/5/25 | Don | Chairman | 10,000,000 | 9.8058% | ||
| 4/14/24 | Others | 6,729,843 | 6.5991% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | +5.95% | -6.84% | -12.97% | 352M | |
| -1.79% | +2.17% | -8.94% | -30.40% | 2.64B | |
| +0.22% | +9.77% | -9.71% | -83.61% | 1.94B | |
| -4.00% | -1.84% | -45.70% | - | 56.44M | |
| Average | -1.52% | +5.51% | -17.80% | -42.33% | 1.25B | |
| Weighted average by Cap. | -0.94% | +10.13% | -9.51% | -50.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103B 72.49M 62.83M 58.9M 53.71M 101M 6.92B 103M 694M 271M 3.46B 272M 266M 11.55B | 118B 83.45M 72.34M 67.81M 61.83M 116M 7.96B 118M 798M 312M 3.99B 313M 307M 13.3B |
| Net income | 55.26B 38.98M 33.78M 31.67M 28.88M 54.33M 3.72B 55.2M 373M 146M 1.86B 146M 143M 6.21B | -87.5B -61.71M -53.49M -50.14M -45.72M -86.03M -5.89B -87.41M -590M -231M -2.95B -232M -227M -9.83B |
| Net Debt | -401B -283M -245M -230M -210M -395M -27.02B -401M -2.71B -1.06B -13.53B -1.06B -1.04B -45.13B | -336B -237M -206M -193M -176M -331M -22.63B -336M -2.27B -886M -11.33B -890M -871M -37.79B |
Employees
298
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | ₩4,900.00 | -0.51% | 64,461 |
| 26-08-12 | ₩4,925.00 | -0.91% | 62,133 |
| 26-08-11 | ₩4,970.00 | +1.43% | 97,752 |
| 26-08-10 | ₩4,900.00 | +1.14% | 76,621 |
| 26-08-07 | ₩4,845.00 | +1.89% | 60,246 |
- Stock Market
- Stocks
- A377740 Stock
Select your edition
All financial news and data tailored to specific country editions
